PATENT CLAIM ANALYSIS

Application Number: 15762050
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-09
Patent Classification: ["424", "209100"]

Abstract:
Provided herein are optimized, recombinant influenza HA polypeptides that elicit immune responses. Also provided are compositions and kits comprising the optimized HA polypeptides as well as methods of making and using the optimized HA polypeptides.

Claim (Index 14):
A method of immunizing a subject against influenza virus, comprising administering to the subject the composition of  claim 13 , wherein administration immunizes the subject against influenza virus.

Metadata:
- Claim Count in Document: 18.0
- Percentile: 90.0
- Lexical Diversity: 1.40741
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14388726', '15051991', '15392710', '14377633', '14376689']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7661061435138515
- 35 USC 102 Novelty (BERT): 0.5337059132429186
- Combined Prediction Score: 0.7428661204867583
- Mean Citation Score: 368.001672
- Max Citation Score: 375.28708
- Similarity Product: 341.16804732930177

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test